TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

$200 Million

TherapeuticsMD

Sole Placement Agent, May 2018

TherapeuticsMD
Senior Secured Term Loan

TherapeuticsMD is a healthcare company focused on developing women’s health products using its patented SYMBODA technology platform. The Company is currently developing advanced hormone therapy pharmaceutical products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes and vaginal dryness. The Company is developing these product candidates, which contain estradiol and progesterone alone or in combination, with the aim of providing equivalent efficacy at lower doses. TherapeuticsMD also manufactures and distributes branded and generic prescription prenatal vitamins, as well as OTC vitamins and cosmetics.

More Like This

Mar 2024

Exchange of all Outstanding Series B Convertible Preferred Stock for Common Stock

Financial Advisor

View Details >
Mar 2024
$600 Million

Follow-on Offering

Bookrunner

View Details >
Mar 2024
$150 Million

Underwritten Offering

Lead Left Bookrunner

View Details >